Robert Wood Email

Managing Director . Britannia Pharmaceuticals

Current Roles

Britannia Pharmaceuticals, part of the STADA Arzneimittel AG group of companies, is a UK based pharmaceutical company specialising in the neurology market. \n\nBritannia focuses on innovative products for chronic and serious medical conditions, and in particular, the treatment of Parkinson’s disease. We are highly committed to improving the quality of life for People with Parkinson's disease. \n\nIf you are interested in viewing any of our current vacancies please go to:
Britannia Pharmaceuticals Address
200 Longwater Avenue
Reading, KS
United States
Britannia Pharmaceuticals Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.